PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas
Abstract Oligodendrogliomas are typically associated with the most favorable prognosis among diffuse gliomas. However, many of the tumors progress, eventually leading to patient death. To characterize the changes associated with oligodendroglioma recurrence and progression, we analyzed two recurrent...
Main Authors: | Kirsi J. Rautajoki, Serafiina Jaatinen, Aliisa M. Tiihonen, Matti Annala, Elisa M. Vuorinen, Anni Kivinen, Minna J. Rauhala, Kendra K. Maass, Kristian W. Pajtler, Olli Yli-Harja, Pauli Helén, Joonas Haapasalo, Hannu Haapasalo, Wei Zhang, Matti Nykter |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-14977-2 |
Similar Items
-
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
by: Kirsi J. Rautajoki, et al.
Published: (2023-11-01) -
Motor dysfunction as a primary symptom predicts poor outcome: multicenter study of glioma symptoms
by: Tomi Kivioja, et al.
Published: (2024-01-01) -
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
by: Birgitta Lehtinen, et al.
Published: (2017-05-01) -
A linear model for transcription factor binding affinity prediction in protein binding microarrays.
by: Matti Annala, et al.
Published: (2011-01-01) -
An integrative prognostic and immune analysis of PTPRD in cancer
by: Chunpei Ou, et al.
Published: (2022-03-01)